AMANDA DIDONATO: Open Payments
NPI 1124848635 · RONKONKOMA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$666 in 11 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $154 · 2025 $666
Food & beverage: $666
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $274 |
| Medtronic, Inc. | 1 | $139 |
| AstraZeneca Pharmaceuticals LP | 1 | $117 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $35 |
| Novo Nordisk Inc | 1 | $26 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
| Amneal Pharmaceuticals LLC | 1 | $23 |
Products named: REXULTI, PERCEPT PC BRAINSENSE, LOKELMA, XIFAXAN, Kerendia, AUSTEDO XR, UNITHROID.
Industry payments across NY — which companies pay providers there.
